🇺🇸 FDA
Pipeline program

alisertib

457403

Phase 1 small_molecule completed

Quick answer

alisertib for Acinar Cell Adenocarcinoma of the Pancreas is a Phase 1 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Acinar Cell Adenocarcinoma of the Pancreas
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials